(Q34352756)

1 August 2017

1 reference

title

The therapeutic use of topical contact sensitizers in benign dermatoses (English)

1 reference

1 August 2017

Buckley DA

1

1 reference

1 August 2017

Du Vivier AW

series ordinal

2

1 reference

1 August 2017

language of work or name

English

0 references

publication date

1 September 2001

1 reference

British Journal of Dermatology

1 August 2017

published in

1 reference

1 August 2017

volume

145

1 reference

1 August 2017

issue

3

1 reference

1 August 2017

page(s)

385-405

1 reference

Immunology of HPV infection and HPV-associated tumors

1 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2001.04399.X

Reduced experimental contact sensitivity in squamous cell but not basal cell carcinomas of skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2001.04399.X

A prospective study of immune responsiveness in human melanoma.I. Assessment of initial pretreatment status with stage of disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2001.04399.X

Induction of hair growth in alopecia areata with D.N.C.B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2001.04399.X

Experiences with local chemotherapy and immunotherapy in premalignant and malignant skin lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2001.04399.X

Alterations of lesions of mycosis fungoides lymphoma by direct imposition of delayed hypersensitivity reactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2001.04399.X

Topical immune modulation with dinitrochlorobenzene in HIV disease: a controlled trial from Brazil

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2001.04399.X

Immunotherapy of non-clinical vaginal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2001.04399.X

Dinitrochlorobenzene treatment of condylomata acuminata

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2001.04399.X

Topical dinitrochlorobenzene therapy in the treatment of refractory atopic dermatitis: systemic immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2001.04399.X

Dinitrochlorobenzene is inherently mutagenic in the presence of trace mutagenic contaminants

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2001.04399.X

Evaluation of the carcinogenic potential of 2,4-dinitrofluorobenzene and its implications regarding mutagenicity testing

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2001.04399.X

Mutagenic and cell transforming activities of 1-chlor-2,4-dinitrobenzene (DNCB) and squaric-acid-dibutylester (SADBE).

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2001.04399.X

Assessment of diphenylcyclopropenone for photochemically induced mutagenicity in the Ames assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2001.04399.X

Topical immunotherapy in alopecia areata. What, how, and why?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2001.04399.X

Contact immunotherapy of resistant warts

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2001.04399.X

Recalcitrant viral warts treated by diphencyprone immunotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2001.04399.X

Diphencyprone in the management of refractory palmoplantar and periungual warts: an open study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2001.04399.X

Alopecia areata in children: response to treatment with diphencyprone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2001.04399.X

Therapy of alopecia areata with diphencyprone

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2001.04399.X

Allergic and irritant contact dermatitis compared in the treatment of alopecia totalis and universalis. A comparison of the value of topical diphencyprone and tretinoin gel.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2001.04399.X

Treatment of alopecia areata with diphencyprone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2001.04399.X

Induction of hair growth in alopecia totalis with diphencyprone sensitization

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2001.04399.X

Contact urticaria during topical immunotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2001.04399.X

Contact urticaria to DNCB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2001.04399.X

Dinitrochlorobenzene immunotherapy for verrucae resistant to standard treatment modalities

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2001.04399.X

Antigenic competition as a therapeutic concept for alopecia areata

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2001.04399.X

Treatment of Alopecia Areata With Dinitrochlorobenzene

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2001.04399.X

Summary of alopecia areata research workshop and future research directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2001.04399.X

Cytokine mRNA levels in Alopecia areata before and after treatment with the contact allergen diphenylcyclopropenone

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2001.04399.X

Topical DNCB therapy for resistant warts

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2001.04399.X

Contact immunotherapy with squaric acid dibutylester for warts [corrected].

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2001.04399.X

Alopecia areata in Korea (1982-1994).

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2001.04399.X

Topical immunotherapy of severe alopecia areata with diphenylcyclopropenone: evaluation of 68 cases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2001.04399.X

Treatment of severe alopecia areata with squaric acid dibutylester in pediatric patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2001.04399.X

Dinitrochlorobenzene Therapy for Alopecia Areata

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2001.04399.X

Response of alopecia areata to DNCB: influence of auto–antibodies and route of sensitization

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2001.04399.X

Dinitrochlorobenzene treatment of alopecia areata.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2001.04399.X

10.1046/J.1365-2133.2001.04399.X

21 January 2018

Identifiers

DOI

1 reference

release_iyya4be2xjb7bmdpxqbj3lir2i

1 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/iyya4be2xjb7bmdpxqbj3lir2i

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference